"Streptococcus pneumoniae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
| Descriptor ID |
D013296
|
| MeSH Number(s) |
B03.353.750.737.872.550 B03.510.400.800.872.550 B03.510.550.737.872.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Streptococcus pneumoniae".
Below are MeSH descriptors whose meaning is more specific than "Streptococcus pneumoniae".
This graph shows the total number of publications written about "Streptococcus pneumoniae" by people in this website by year, and whether "Streptococcus pneumoniae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 1 | 7 |
| 1995 | 10 | 2 | 12 |
| 1996 | 6 | 1 | 7 |
| 1997 | 6 | 1 | 7 |
| 1998 | 6 | 5 | 11 |
| 1999 | 5 | 0 | 5 |
| 2000 | 5 | 3 | 8 |
| 2001 | 8 | 4 | 12 |
| 2002 | 7 | 3 | 10 |
| 2003 | 3 | 5 | 8 |
| 2004 | 4 | 3 | 7 |
| 2005 | 5 | 2 | 7 |
| 2006 | 6 | 3 | 9 |
| 2007 | 5 | 1 | 6 |
| 2008 | 2 | 1 | 3 |
| 2009 | 3 | 1 | 4 |
| 2010 | 5 | 2 | 7 |
| 2011 | 7 | 4 | 11 |
| 2012 | 8 | 1 | 9 |
| 2013 | 2 | 3 | 5 |
| 2014 | 4 | 1 | 5 |
| 2015 | 5 | 1 | 6 |
| 2016 | 9 | 2 | 11 |
| 2017 | 4 | 2 | 6 |
| 2018 | 5 | 3 | 8 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 2 | 3 |
| 2021 | 2 | 4 | 6 |
| 2022 | 1 | 3 | 4 |
| 2023 | 2 | 2 | 4 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Streptococcus pneumoniae" by people in Profiles.
-
Neighborhood-level disadvantages increase risk for invasive pneumococcal disease. Am J Med Sci. 2024 05; 367(5):304-309.
-
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):137-147.
-
Development and validation of a multiplex real-time PCR assay for detection and quantification of Streptococcus pneumoniae in pediatric respiratory samples. Microbiol Spectr. 2023 Dec 12; 11(6):e0211823.
-
Development and performance of a multiplex PCR assay for the?detection of bacteria in sterile body fluids. Future Microbiol. 2023 02; 18:187-195.
-
Amoxicillin and penicillin G dosing in pediatric community-acquired pneumococcal pneumonia in the era of conjugate pneumococcal vaccines. Pharmacotherapy. 2024 Aug; 44(8):606-614.
-
The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures. Clin Microbiol Rev. 2022 12 21; 35(4):e0001522.
-
Diagnostic Accuracy of MRI for Detection of Meningitis in Infants. AJNR Am J Neuroradiol. 2022 09; 43(9):1350-1355.
-
Contribution of Puma to Inflammatory Resolution During Early Pneumococcal Pneumonia. Front Cell Infect Microbiol. 2022; 12:886901.
-
International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease. Vaccine. 2022 02 11; 40(7):1054-1060.
-
Increase in Penicillin and multidrug resistance in Streptococcus pneumoniae (1993-2016): Report from a tertiary care hospital laboratory, Pakistan. J Pak Med Assoc. 2021 Dec; 71(12):2726-2730.